Literature DB >> 33801839

Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against Elizabethkingia anophelis Using In Vitro Time-Kill Assays and In Vivo Zebrafish Animal Models.

Jiun-Nong Lin1,2,3, Chung-Hsu Lai2,3, Yi-Han Huang3, Chih-Hui Yang4.   

Abstract

Elizabethkingia anophelis is a multidrug-resistant pathogen. This study evaluated the antimicrobial activity of minocycline, tigecycline, ciprofloxacin, and levofloxacin using in vitro time-kill assays and in vivo zebrafish animal models. The E. anophelis strain ED853-49 was arbitrarily selected from a bacterial collection which was concomitantly susceptible to minocycline, tigecycline, ciprofloxacin, and levofloxacin. The antibacterial activities of single agents at 0.5-4 × minimum inhibitory concentration (MIC) and dual-agent combinations at 2 × MIC using time-kill assays were investigated. The therapeutic effects of antibiotics in E. anophelis-infected zebrafish were examined. Both minocycline and tigecycline demonstrated bacteriostatic effects but no bactericidal effect. Minocycline at concentrations ≥2 × MIC and tigecycline at concentrations ≥3 × MIC exhibited a long-standing inhibitory effect for 48 h. Bactericidal effects were observed at ciprofloxacin and levofloxacin concentrations of ≥3 × MIC within 24 h of initial inoculation. Rapid regrowth of E. anophelis occurred after the initial killing phase when ciprofloxacin was used, regardless of the concentration. Levofloxacin treatment at the concentration of ≥2 × MIC consistently resulted in the long-lasting and sustainable inhibition of bacterial growth for 48 h. The addition of minocycline or tigecycline weakened the killing effect of fluoroquinolones during the first 10 h. The minocycline-ciprofloxacin or minocycline-levofloxacin combinations achieved the lowest colony-forming unit counts at 48 h. Zebrafish treated with minocycline or a combination of minocycline and levofloxacin had the highest survival rate (70%). The results of these in vitro and in vivo studies suggest that the combination of minocycline and levofloxacin is the most effective therapy approach for E. anophelis infection.

Entities:  

Keywords:  Elizabethkingia anophelis; ciprofloxacin; levofloxacin; minocycline; tigecycline; zebrafish

Year:  2021        PMID: 33801839      PMCID: PMC7999888          DOI: 10.3390/antibiotics10030285

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  32 in total

1.  SEPSIS KILLS: early intervention saves lives.

Authors:  Anthony R Burrell; Mary-Louise McLaws; Mary Fullick; Rosemary B Sullivan; Doungkamol Sindhusake
Journal:  Med J Aust       Date:  2016-02-01       Impact factor: 7.738

2.  In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis.

Authors:  Peter J Petersen; Ponpen Labthavikul; C Hal Jones; Patricia A Bradford
Journal:  J Antimicrob Chemother       Date:  2006-01-23       Impact factor: 5.790

3.  Clinical manifestations, molecular characteristics, antimicrobial susceptibility patterns and contributions of target gene mutation to fluoroquinolone resistance in Elizabethkingia anophelis.

Authors:  Jiun-Nong Lin; Chung-Hsu Lai; Chih-Hui Yang; Yi-Han Huang; Hsi-Hsun Lin
Journal:  J Antimicrob Chemother       Date:  2018-09-01       Impact factor: 5.790

4.  Development of an Animal Model for Alcoholic Liver Disease in Zebrafish.

Authors:  Jiun-Nong Lin; Lin-Li Chang; Chung-Hsu Lai; Kai-Jen Lin; Mei-Fang Lin; Chih-Hui Yang; Hsi-Hsun Lin; Yen-Hsu Chen
Journal:  Zebrafish       Date:  2015-04-29       Impact factor: 1.985

5.  In vitro effectiveness of colistin, tigecycline and levofloxacin alone and combined with clarithromycin and/or heparin as lock solutions against embedded Acinetobacter baumannii strains.

Authors:  Berna Ozbek; Emel Mataraci
Journal:  J Antimicrob Chemother       Date:  2012-11-29       Impact factor: 5.790

6.  Biofilm formation and adherence characteristics of an Elizabethkingia meningoseptica isolate from Oreochromis mossambicus.

Authors:  Anelet Jacobs; Hafizah Y Chenia
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-05-05       Impact factor: 3.944

7.  Elizabethkingia anophelis bacteremia is associated with clinically significant infections and high mortality.

Authors:  Susanna K P Lau; Wang-Ngai Chow; Chuen-Hing Foo; Shirly O T Curreem; George Chi-Shing Lo; Jade L L Teng; Jonathan H K Chen; Ricky H Y Ng; Alan K L Wu; Ingrid Y Y Cheung; Sandy K Y Chau; David C Lung; Rodney A Lee; Cindy W S Tse; Kitty S C Fung; Tak-Lun Que; Patrick C Y Woo
Journal:  Sci Rep       Date:  2016-05-17       Impact factor: 4.379

8.  Waterborne Elizabethkingia meningoseptica in Adult Critical Care.

Authors:  Luke S P Moore; Daniel S Owens; Annette Jepson; Jane F Turton; Simon Ashworth; Hugo Donaldson; Alison H Holmes
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

9.  Elizabethkingia anophelis and Association with Tap Water and Handwashing, Singapore.

Authors:  Chee-Fu Yung; Matthias Maiwald; Liat H Loo; Han Y Soong; Chin B Tan; Phaik K Lim; Ling Li; Natalie Wh Tan; Chia-Yin Chong; Nancy Tee; Koh C Thoon; Yoke H Chan
Journal:  Emerg Infect Dis       Date:  2018-09       Impact factor: 6.883

10.  Comparison of Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Elizabethkingia meningoseptica and Elizabethkingia anophelis Isolated in Taiwan.

Authors:  Jiun-Nong Lin; Chung-Hsu Lai; Chih-Hui Yang; Yi-Han Huang
Journal:  J Clin Med       Date:  2018-12-11       Impact factor: 4.241

View more
  1 in total

1.  The Evolutionary Trend and Genomic Features of an Emerging Lineage of Elizabethkingia anophelis Strains in Taiwan.

Authors:  Yu-Lin Lee; Kuan-Ming Liu; Hui-Lan Chang; Yi-Ci Liao; Jen-Shiou Lin; Fang-Yen Kung; Cheng-Mao Ho; Kai-Hsiang Lin; Ying-Tsong Chen
Journal:  Microbiol Spectr       Date:  2022-01-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.